UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy

European journal of cancer (1990), 2017-05, Vol.76, p.167-182

2017

Volltextzugriff (PDF)

Effects of broad-spectrum antibiotics on the colonisation of probiotic yeast Saccharomyces boulardii in the murine gastrointestinal tract

Scientific reports, 2022-05, Vol.12 (1), p.8862-8862, Article 8862

2022

Volltextzugriff (PDF)

A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases

Cancer Immunology, Immunotherapy, 2020-12, Vol.69 (12), p.2589-2598

2020

Volltextzugriff (PDF)

Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma

Nature communications, 2018-07, Vol.9 (1), p.2921-3, Article 2921

2018

Volltextzugriff (PDF)

Exploring a New Entity of Single-Agent Pembrolizumab-Associated Hypophysitis

Curēus (Palo Alto, CA), 2022-08

2022

Volltextzugriff (PDF)

Psoriasis Vulgaris Exacerbation during Treatment with a PD-1 Checkpoint Inhibitor: Case Report and Literature Review

Case reports in dermatology, 2018-05, Vol.10 (2), p.190-197

2018

Volltextzugriff (PDF)

Biocontainment strategies for in vivo applications of Saccharomyces boulardii

Frontiers in bioengineering and biotechnology, 2023-02, Vol.11, p.1136095

2023

Volltextzugriff (PDF)

Phase 1 Dose Escalation Trial of Ipilimumab and Stereotactic Body Radiation Therapy in Metastatic Melanoma

International journal of radiation oncology, biology, physics, 2018-03, Vol.100 (4), p.906-915

2018

Volltextzugriff (PDF)

Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy

Frontiers in immunology, 2021-12, Vol.12, p.789473-789473

2021

Volltextzugriff (PDF)

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled trial

BMC cancer, 2021-05, Vol.21 (1), p.514-10, Article 514

2021

Volltextzugriff (PDF)

Mental Health and Quality of Life among Patients with Cancer during the SARS-CoV-2 Pandemic: Results from the Longitudinal ONCOVID Survey Study

Cancers, 2022-02, Vol.14 (4), p.1093

2022

Volltextzugriff (PDF)

Managing viral hepatitis in cancer patients under immune checkpoint inhibitors: should we take the risk?

Immunotherapy, 2021-04, Vol.13 (5), p.409-418

2021

Volltextzugriff (PDF)

Epidermal Acyl-CoA-binding protein is indispensable for systemic energy homeostasis

Molecular metabolism (Germany), 2021-02, Vol.44, p.101144-101144, Article 101144

2021

Volltextzugriff (PDF)

Immune Monitoring in Melanoma and Urothelial Cancer Patients Treated with Anti-PD-1 Immunotherapy and SBRT Discloses Tumor Specific Immune Signatures

Cancers, 2021-05, Vol.13 (11), p.2630

2021

Volltextzugriff (PDF)

Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation Trial

Targeted oncology, 2021-01, Vol.16 (1), p.47-57

2021

Volltextzugriff (PDF)

Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreated patients with advanced BRAFV600 -mutant melanoma: an open-label, single arm, dual-centre, phase 2 clinical trial

The lancet oncology, 2017-04, Vol.18 (4), p.464-472

2017

Volltextzugriff (PDF)

Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid Tumors

Targeted oncology, 2021, Vol.16 (1), p.37-46

2021

Volltextzugriff (PDF)

Serum tumor markers and PET/CT imaging for tumor recurrence detection

Annals of nuclear medicine, 2013-02, Vol.27 (2), p.97-104

2013

Volltextzugriff (PDF)

Copy number variation analysis and methylome profiling of a GNAQ-mutant primary meningeal melanocytic tumor and its liver metastasis

Experimental and molecular pathology, 2017-02, Vol.102 (1), p.25-31

2017

Volltextzugriff (PDF)

Phase 2 Trial of Nivolumab Combined With Stereotactic Body Radiation Therapy in Patients With Metastatic or Locally Advanced Inoperable Melanoma

International journal of radiation oncology, biology, physics, 2019-07, Vol.104 (4), p.828-835

2019

Volltextzugriff (PDF)

Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours

European journal of nuclear medicine and molecular imaging, 2013, Vol.40 (2), p.290-301

2013

Volltextzugriff (PDF)

Strategies to overcome relapse of immunotherapy-related hepatitis: dose reduction is not the key

Acta clinica belgica (English ed. Online), 2022-06, Vol.77 (3), p.546-551

2022

Volltextzugriff (PDF)

Burden of skin cancer in Belgium and cost-effectiveness of primary prevention by reducing ultraviolet exposure

Preventive medicine, 2016-12, Vol.93, p.177-182

2016

Volltextzugriff (PDF)

Immune checkpoint blockade for organ transplant patients with advanced cancer: how far can we go?

Current opinion in oncology, 2019-03, Vol.31 (2), p.54-64

2019

Volltextzugriff (PDF)

Bilateral Corneal Graft Rejection Associated With Pembrolizumab Treatment

Cornea, 2020-11, Vol.39 (11), p.1436-1438

2020

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(50)

Publikationsform

Sprache

Englisch
(68)
Dänisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(4)
Acta Clinica Belgica
(3)
Cancers
(2)
Cardiology In The Young
(2)
Curēus
(2)
International Journal Of Radiation Oncology, Biology, Physics
(2)
Melanoma Research
(2)
Oncotarget
(2)
Scientific Reports
(2)
Targeted Oncology
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy

Effects of broad-spectrum antibiotics on the colonisation of probiotic yeast Saccharomyces boulardii in the murine gastrointestinal tract

A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases

Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma

Exploring a New Entity of Single-Agent Pembrolizumab-Associated Hypophysitis

Psoriasis Vulgaris Exacerbation during Treatment with a PD-1 Checkpoint Inhibitor: Case Report and Literature Review

Biocontainment strategies for in vivo applications of Saccharomyces boulardii

Phase 1 Dose Escalation Trial of Ipilimumab and Stereotactic Body Radiation Therapy in Metastatic Melanoma

Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled trial

Mental Health and Quality of Life among Patients with Cancer during the SARS-CoV-2 Pandemic: Results from the Longitudinal ONCOVID Survey Study

Managing viral hepatitis in cancer patients under immune checkpoint inhibitors: should we take the risk?

Epidermal Acyl-CoA-binding protein is indispensable for systemic energy homeostasis

Immune Monitoring in Melanoma and Urothelial Cancer Patients Treated with Anti-PD-1 Immunotherapy and SBRT Discloses Tumor Specific Immune Signatures

Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation Trial

Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreated patients with advanced BRAFV600 -mutant melanoma: an open-label, single arm, dual-centre, phase 2 clinical trial

Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid Tumors

Serum tumor markers and PET/CT imaging for tumor recurrence detection

Copy number variation analysis and methylome profiling of a GNAQ-mutant primary meningeal melanocytic tumor and its liver metastasis

Phase 2 Trial of Nivolumab Combined With Stereotactic Body Radiation Therapy in Patients With Metastatic or Locally Advanced Inoperable Melanoma

Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours

Strategies to overcome relapse of immunotherapy-related hepatitis: dose reduction is not the key

Burden of skin cancer in Belgium and cost-effectiveness of primary prevention by reducing ultraviolet exposure

Immune checkpoint blockade for organ transplant patients with advanced cancer: how far can we go?

Bilateral Corneal Graft Rejection Associated With Pembrolizumab Treatment

Suchergebnisse filtern